A detailed history of D. E. Shaw & Co., Inc. transactions in Liva Nova PLC stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 446,638 shares of LIVN stock, worth $22.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
446,638
Holding current value
$22.3 Million
% of portfolio
0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$43.38 - $54.59 $11 Million - $13.9 Million
254,355 Added 132.28%
446,638 $23.5 Million
Q2 2024

Aug 14, 2024

SELL
$51.76 - $64.15 $4.02 Million - $4.98 Million
-77,672 Reduced 28.77%
192,283 $10.5 Million
Q1 2024

May 15, 2024

BUY
$48.6 - $57.12 $2.14 Million - $2.51 Million
44,009 Added 19.48%
269,955 $15.1 Million
Q4 2023

Feb 14, 2024

SELL
$43.45 - $53.66 $2.58 Million - $3.19 Million
-59,419 Reduced 20.82%
225,946 $11.7 Million
Q3 2023

Nov 14, 2023

SELL
$50.12 - $58.87 $5.15 Million - $6.04 Million
-102,655 Reduced 26.46%
285,365 $15.1 Million
Q2 2023

Aug 14, 2023

SELL
$42.28 - $51.43 $3.23 Million - $3.93 Million
-76,446 Reduced 16.46%
388,020 $20 Million
Q1 2023

May 15, 2023

BUY
$40.84 - $58.14 $7.44 Million - $10.6 Million
182,074 Added 64.48%
464,466 $20.2 Million
Q4 2022

Feb 14, 2023

BUY
$43.88 - $56.16 $5.78 Million - $7.4 Million
131,830 Added 87.56%
282,392 $15.7 Million
Q3 2022

Nov 14, 2022

BUY
$48.37 - $66.5 $3.43 Million - $4.72 Million
71,014 Added 89.27%
150,562 $7.64 Million
Q2 2022

Aug 15, 2022

SELL
$57.25 - $86.63 $338,118 - $511,636
-5,906 Reduced 6.91%
79,548 $4.97 Million
Q1 2022

May 16, 2022

BUY
$71.02 - $86.99 $2.84 Million - $3.47 Million
39,946 Added 87.78%
85,454 $6.99 Million
Q4 2021

Feb 14, 2022

SELL
$76.72 - $92.68 $1.46 Million - $1.77 Million
-19,068 Reduced 29.53%
45,508 $3.98 Million
Q3 2021

Nov 15, 2021

BUY
$76.02 - $88.62 $2.67 Million - $3.11 Million
35,122 Added 119.24%
64,576 $5.11 Million
Q2 2021

Aug 16, 2021

SELL
$73.44 - $87.01 $980,570 - $1.16 Million
-13,352 Reduced 31.19%
29,454 $2.48 Million
Q1 2021

May 17, 2021

SELL
$62.9 - $82.41 $2.94 Million - $3.86 Million
-46,802 Reduced 52.23%
42,806 $3.16 Million
Q4 2020

Feb 16, 2021

SELL
$46.01 - $68.74 $7.34 Million - $11 Million
-159,526 Reduced 64.03%
89,608 $5.93 Million
Q3 2020

Nov 16, 2020

SELL
$41.91 - $57.81 $12 Million - $16.5 Million
-286,237 Reduced 53.47%
249,134 $11.3 Million
Q2 2020

Aug 14, 2020

BUY
$39.87 - $56.9 $248,908 - $355,226
6,243 Added 1.18%
535,371 $25.8 Million
Q1 2020

May 15, 2020

SELL
$34.22 - $76.49 $4 Million - $8.94 Million
-116,943 Reduced 18.1%
529,128 $23.9 Million
Q4 2019

Feb 14, 2020

BUY
$68.92 - $85.27 $9.49 Million - $11.7 Million
137,629 Added 27.07%
646,071 $48.7 Million
Q3 2019

Nov 14, 2019

BUY
$71.74 - $86.35 $8.34 Million - $10 Million
116,293 Added 29.66%
508,442 $37.5 Million
Q2 2019

Aug 14, 2019

BUY
$66.45 - $97.36 $24.6 Million - $36 Million
369,885 Added 1661.36%
392,149 $28.2 Million
Q1 2019

May 15, 2019

SELL
$86.15 - $100.49 $1.57 Million - $1.83 Million
-18,258 Reduced 45.06%
22,264 $2.17 Million
Q4 2018

Feb 14, 2019

SELL
$84.14 - $125.42 $2.19 Million - $3.26 Million
-25,993 Reduced 39.08%
40,522 $3.71 Million
Q3 2018

Nov 14, 2018

SELL
$101.02 - $130.95 $1.15 Million - $1.49 Million
-11,405 Reduced 14.64%
66,515 $8.25 Million
Q2 2018

Aug 14, 2018

SELL
$81.75 - $105.37 $4.35 Million - $5.61 Million
-53,267 Reduced 40.6%
77,920 $7.78 Million
Q1 2018

May 15, 2018

BUY
$79.95 - $89.74 $975,230 - $1.09 Million
12,198 Added 10.25%
131,187 $11.6 Million
Q4 2017

Feb 14, 2018

BUY
$71.8 - $88.21 $5.26 Million - $6.46 Million
73,209 Added 159.91%
118,989 $9.51 Million
Q3 2017

Nov 14, 2017

BUY
$60.32 - $70.06 $2.76 Million - $3.21 Million
45,780
45,780 $3.21 Million

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.68B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.